Communication Bridge: Optimizing an Evidence-based Intervention for Individuals With Primary Progressive Aphasia
Communication Bridge: Optimizing an Evidence-based Intervention for Individuals With Primary Progressive Aphasia
This study will use a randomized controlled trial design to evaluate the effect of two evidence-based treatments for adults with mild-moderate Primary Progressive Aphasia (PPA). The aim of the study is to help us better understand the effects of speech-language therapy on communication abilities in individuals with PPA.
Participants with a diagnosis of PPA and their actively-engaged care partners will be involved in the study for approximately 17 months. Each participant will receive a laptop equipped with the necessary applications and features for the study. Participants will receive up to 10 evaluations and 20 speech therapy sessions with a licensed speech therapist, as well as access to Communication Bridge, a personalized web application to practice home exercises that reinforce treatment strategies. There are no costs to participate in this study.
Inclusion Criteria (person with PPA):
Inclusion Criteria (Co-enrolled communication partner):
Exclusion Criteria:
Medical records will be requested and reviewed to determine eligibility
cbtrial@uchicago.edu773-702-1220 ext. 51145
cbtrial@uchicago.edu773-702-1221